Aspirin Metabolites and Mammographic Breast Density in Premenopausal Women.

Ramkrishna Kumar Singh Kayla R Getz Joy K Kyeyune Myung Sik Jeon Chongliang Luo Jingqin R Luo Adetunji T Toriola

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)

Elucidating the determinants of MBD, a strong risk factor for breast cancer, can play an important role in breast cancer prevention. Future studies should determine the associations of non-aspirin non-steroidal anti-inflammatory drug metabolites with MBD.

Keyphrases

breast cancer risk
low dose
anti inflammatory drugs
ms ms
anti inflammatory
cardiovascular events
antiplatelet therapy
polycystic ovary syndrome
postmenopausal women
current status
emergency department
type diabetes
cardiovascular disease
pregnancy outcomes
adipose tissue
insulin resistance
drug induced